FR2818648B1 - Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih - Google Patents
Antigenes proteiques inducteurs d'anticorps neutralisant le virus vihInfo
- Publication number
- FR2818648B1 FR2818648B1 FR0016986A FR0016986A FR2818648B1 FR 2818648 B1 FR2818648 B1 FR 2818648B1 FR 0016986 A FR0016986 A FR 0016986A FR 0016986 A FR0016986 A FR 0016986A FR 2818648 B1 FR2818648 B1 FR 2818648B1
- Authority
- FR
- France
- Prior art keywords
- neutralizing antibodies
- hiv virus
- protein antigens
- virus neutralizing
- inducing hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0016986A FR2818648B1 (fr) | 2000-12-22 | 2000-12-22 | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih |
AU2002219290A AU2002219290A1 (en) | 2000-12-22 | 2001-12-12 | Proteinic antigens inducing antibodies neutralising hiv virus |
PCT/FR2001/003957 WO2002051865A2 (fr) | 2000-12-22 | 2001-12-12 | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0016986A FR2818648B1 (fr) | 2000-12-22 | 2000-12-22 | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2818648A1 FR2818648A1 (fr) | 2002-06-28 |
FR2818648B1 true FR2818648B1 (fr) | 2003-10-10 |
Family
ID=8858164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0016986A Expired - Fee Related FR2818648B1 (fr) | 2000-12-22 | 2000-12-22 | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2818648B1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035194A2 (fr) * | 1996-03-21 | 1997-09-25 | President And Fellows Of Harvard College | Procede de criblage enantiomere et compositions pour ce procede |
AU748700B2 (en) * | 1998-06-12 | 2002-06-13 | Aventis Pasteur | HIV virus mimotopes |
-
2000
- 2000-12-22 FR FR0016986A patent/FR2818648B1/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
FR2818648A1 (fr) | 2002-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
ID30380A (id) | Penghambatan infeksi virus menggunakan protein pengikat antigen bervalensi tunggal | |
DE60125797D1 (de) | Impfstoffzusammesetzung | |
NO20023829L (no) | Proteosom influensavaksine | |
IS7133A (is) | Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni | |
HUP0303134A3 (en) | Hiv peptides, antigens, vaccine compositions, immunoassay kits and method of detecting antibodies induced by hiv | |
EA200801798A1 (ru) | Виросомоподобные везикулы, содержащие антигены, производные от gp41 | |
IL221708A0 (en) | Polyclonal goat anti-hla class ii antibody for treatment of disease involving proliferative immune response | |
ATE485833T1 (de) | Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern | |
NO20030239D0 (no) | Modifisert virus | |
HUP0302681A2 (hu) | Protein antigének hősokk fehérjékhez való gerelyszerű hozzákötése | |
BR0109164A (pt) | Anticorpos monoclonais para o receptor humano para ldl, produção e uso dos mesmos | |
NO20033829L (no) | Virusdrepende preparater | |
DK1035133T3 (da) | Fusionsproteiner, der omfatter bærere, som kan inducere et dobbelt immunrespons | |
FR2815634B1 (fr) | Anticorps monoclonaux diriges contre des virus de l'hepatite b | |
DE60042130D1 (de) | Neue antigene hev-peptide und methoden | |
FR2818648B1 (fr) | Antigenes proteiques inducteurs d'anticorps neutralisant le virus vih | |
FR2741077B1 (fr) | Vaccin polyvalent anti-dengue | |
ATE346087T1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
FR2819256B1 (fr) | Polypeptide induisant des anticorps neutralisant le vih | |
FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih | |
AR020852A1 (es) | Antigenos de vacuna de leptospira para la prevencion de leptospirosis | |
AU2002219290A1 (en) | Proteinic antigens inducing antibodies neutralising hiv virus | |
RU2001127052A (ru) | Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов | |
WO2002000252A3 (fr) | Tolerance et virus de l'hepatite c chronique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CD | Change of name or company name | ||
ST | Notification of lapse |
Effective date: 20090831 |